Literature DB >> 32222292

Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77: 508-47 https://doi.org/10.1016/j.eururo.2020.01.012.

Finn Edler von Eyben1, Glenn Bauman2, Cigdem Soydal3, Giovanni Paganelli4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32222292     DOI： 10.1016/j.eururo.2020.03.012

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with 177Lu-PSMA radioligand therapy.

Authors:  Finn Edler von Eyben; Harshad R Kulkarni; Richard P Baum
Journal:  Theranostics       Date:  2020-03-30       Impact factor: 11.556
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.